Szeőcs, Dóra
Vida, Beáta
Petővári, Gábor
Póliska, Szilárd
Janka, Eszter
Sipos, Adrienn
Uray, Karen
Sebestyén, Anna
Krasznai, Zoárd
Bai, Péter http://orcid.org/0000-0002-6191-6616
Funding for this research was provided by:
NKFIH (K142141, FK128387, TKP2021-EGA-19, TKP2021-EGA-20)
Magyar Tudományos Akadémia (Bolyai Fellowship, NKM2022-30, POST-COVID2021-33)
Nemzeti Kutatási Fejlesztési és Innovációs Hivatal (FK146852)
University of Debrecen
Article History
Received: 13 September 2023
Accepted: 24 December 2023
First Online: 10 January 2024
Declarations
:
: The manuscript does not contain data or photographs through which individuals can be identified.
: Péter Bai is a CEO and shareholder of Holobiont Diagnostics LTD, a developer of cancer diagnostic tests. Other authors declare no conflict of interest.
: Primary data is available at the Figshare.com repository ExternalRef removedExternalRef removed). The results of the RNA sequencing dataset were uploaded to the NCBI SRA database (Submission ID: SUB12949677; BioProject ID: PRJNA944542).